Devex Examines USAID’s TB Strategy In Kyrgyzstan, Globally

Devex: USAID’s TB strategy as seen from Kyrgyzstan
“…USAID’s TB strategy worldwide … is twofold: focusing on local capacity building in order to ultimately rely on local solutions and resources; as well as funding research and development to move to a purely oral treatment regimen in concordance with the latest World Health Organization guidelines. In Kyrgyzstan and other post-Soviet states, USAID’s strategy to defeat TB includes cutting health care expenditures — in part by putting an end to interminable hospital stays. What this looks like on the ground is shortened treatment regimens for drug-resistant TB, and limiting hospital stays to two months or until patients are no longer contagious, with treatment continued on an outpatient basis and supplemented with support and follow-up by social workers…” (Ravindran, 4/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.